This receptor can suppress the EGFR/MAPK and PI3K/AKT signaling pathways in pancreatic cancer cells, thereby reducing the number and activity of cancer stem cells and also inhibiting the formation of liver metastases (19). The gene discussed is AKT1; the disease is familial pancreatic carcinoma.